Douglas J. Hughes, Director at Immunovant, Inc. (IMVT), sold 10,850 shares at $28.54 ($310K) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Scheduled sale ($310k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.54 | 5,425 | $155K | 50.0% |
| 2 | $28.54 | 5,425 | $155K | 50.0% |
| Total | $28.54 avg | 10,850 | $310K | 100% |
| Filing → |
| EAR | SELL | 2021-04-28 | $83K | — | Filing → |